Published in Mol Biol (Mosk) on November 23, 2010
Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling. Leukemia (2014) 1.04
Deregulation of RAD21 and RUNX1 expression in endometrial cancer. Oncol Lett (2012) 0.80
A new system for parallel drug screening against multiple-resistant HIV mutants based on lentiviral self-inactivating (SIN) vectors and multi-colour analyses. AIDS Res Ther (2013) 0.78
The structure of the yeast ribosomal RNA genes. I. The complete nucleotide sequence of the 18S ribosomal RNA gene from Saccharomyces cerevisiae. Nucleic Acids Res (1980) 7.85
An alternative strategy for studying adverse events in medical care. Lancet (1997) 5.98
Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol (1995) 5.86
Effects of organizational change in the medical intensive care unit of a teaching hospital: a comparison of 'open' and 'closed' formats. JAMA (1996) 4.71
A variation in the structure of the protein-coding region of the human p53 gene. Gene (1988) 3.03
The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature (1998) 2.86
Physicians' attitudes about the care of patients in the persistent vegetative state: a national survey. Ann Intern Med (1996) 2.85
Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc Natl Acad Sci U S A (1996) 2.66
Ethics consultants' recommendations for life-prolonging treatment of patients in a persistent vegetative state. JAMA (1993) 1.91
Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus. Proc Natl Acad Sci U S A (1985) 1.88
The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res (1995) 1.73
Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proc Natl Acad Sci U S A (1987) 1.68
Retroviral mutants efficiently expressed in embryonal carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.60
[Full sequence of the nucleotides of the spacer region located between the genes for yeast 18S and 5.8S RNA]. Dokl Akad Nauk SSSR (1979) 1.58
Autocrine stimulation after transfer of the granulocyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway. Proc Natl Acad Sci U S A (1987) 1.57
[Determination of the primary structure of fragments of the ribosomal operon of baker's yeast coding for 18 S rRNA]. Dokl Akad Nauk SSSR (1979) 1.52
[The loss of the subject of science]. Voen Med Zh (1994) 1.45
Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation. J Virol (1998) 1.42
Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol (1995) 1.42
The nucleotide sequence of the gene coding for the 16S rRNA from the archaebacterium Halobacterium halobium. Gene (1985) 1.40
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proc Natl Acad Sci U S A (2008) 1.36
Putative promoter region of rRNA operon from archaebacterium Halobacterium halobium. Nucleic Acids Res (1984) 1.36
Bone marrow transplantation for sickle cell disease. A study of parents' decisions. N Engl J Med (1991) 1.33
Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus. Virology (1986) 1.30
Viral transfer, transcription, and rescue of a selectable myeloproliferative sarcoma virus in embryonal cell lines: expression of the mos oncogene. Mol Cell Biol (1986) 1.29
Requirements for ethics, socioeconomic, and legal education in postgraduate medical programs. J Clin Ethics (1993) 1.27
Sex or survival: trade-offs between quality and quantity of life. J Clin Oncol (1991) 1.26
The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells. Gene (1991) 1.24
Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons. J Clin Oncol (1992) 1.24
Chromosome changes caused by alterations of p53 expression. Mutat Res (1996) 1.22
The gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: evidence for differentiation stage-specific regulation. Mol Cell Biol (1992) 1.21
Molecular cloning and characterization of a leukemia-inducing myeloproliferative sarcoma virus and two of its temperature-sensitive mutants. J Virol (1984) 1.20
Isolation of ribosomal subunits containing intact rRNA from human placenta: estimation of functional activity of 80S ribosomes. Anal Biochem (1991) 1.18
Retroviral vectors related to the myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells. Hum Gene Ther (1991) 1.11
[Nucleotide sequence of the proposed transcription initiation region of the yeast ribosome operon]. Dokl Akad Nauk SSSR (1979) 1.10
Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1. Gene (2005) 1.07
Transforming genes and target cells of murine spleen focus-forming viruses. Adv Cancer Res (1987) 1.06
Identification of ten additional nucleotides in the primary structure of yeast 18S rRNA. Gene (1986) 1.06
Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells. Oncogene (2008) 1.05
Expression of the GM-CSF gene after retroviral transfer in hematopoietic stem cell lines induces synchronous granulocyte-macrophage differentiation. Cell (1991) 1.04
RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress. Oncogene (2009) 1.03
Internal medicine residents' preferences regarding medical ethics education. Acad Med (1989) 1.00
Carboxyl-truncated STAT5beta is generated by a nucleus-associated serine protease in early hematopoietic progenitors. Blood (1998) 1.00
Disruption of actin microfilaments by cytochalasin D leads to activation of p53. FEBS Lett (1998) 1.00
Gadd45 beta is a pro-survival factor associated with stress-resistant tumors. Oncogene (2007) 0.99
The myeloproliferative sarcoma virus retains transforming functions after introduction of a dominant selectable marker gene. J Gen Virol (1986) 0.98
RNase T1 mimicking artificial ribonuclease. Nucleic Acids Res (2007) 0.95
Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy. Proc Natl Acad Sci U S A (1997) 0.95
Studying functional significance of the sequence 980-1061 in the central domain of human 18S rRNA using complementary DNA probes. Biochim Biophys Acta (1997) 0.94
P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints. Oncogene (1999) 0.94
Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation. J Cell Sci (1998) 0.94
p53 does not control the spindle assembly cell cycle checkpoint but mediates G1 arrest in response to disruption of microtubule system. Cell Biol Int (1999) 0.93
[Automated H-phosphonate synthesis of oligoribonucleotides using 2'-O-tetrahydropyranyl protective group]. Bioorg Khim (1990) 0.93
p53 activation in response to microtubule disruption is mediated by integrin-Erk signaling. Oncogene (2001) 0.93
[Retroviral reporter systems for the assessment of activity of stress-induced signal transduction pathways controlled by p53, HIF-1 and HSF-1 transcription factors]. Mol Biol (Mosk) (2005) 0.90
Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice. Immunol Lett (1988) 0.89
Arrangement of mRNA at the decoding site of human ribosomes. 18S rRNA nucleotides and ribosomal proteins cross-linked to oligouridylate derivatives with alkylating groups at either the 3' or the 5' termini. Eur J Biochem (1994) 0.89
Activated leukemic oncogenes AML1-ETO and c-kit: role in development of acute myeloid leukemia and current approaches for their inhibition. Biochemistry (Mosc) (2010) 0.89
Optimization of a Genome-Wide Disordered Lentivector-Based Short Hairpin RNA Library. Mol Biol (2006) 0.89
Standards and limits: emergency physicians' attitude toward prehospital resuscitation. Am J Emerg Med (1993) 0.89
Entry of amphotropic and 10A1 pseudotyped murine retroviruses is restricted in hematopoietic stem cell lines. J Virol (1998) 0.89
Retrotransposons as mutagens in the induction of growth autonomy in hematopoietic cells. Oncogene (1990) 0.88
Induction of monocytic differentiation and tumorigenicity by v-Ha-ras in differentiation arrested hematopoietic cells. Blood (1993) 0.88
[In vitro suppression of translation of tick-borne encephalitis virus RNA using antisense nucleotides]. Mol Biol (Mosk) (1993) 0.87
[Model of the secondary structure of eukaryotic ribosomal 18 S rRNA]. Dokl Akad Nauk SSSR (1981) 0.87
Tube feeding. Internists' attitudes regarding ethical obligations. Arch Intern Med (1994) 0.87
[RNA hydrolysis catalyzed by imidazole as a reaction for studying the secondary structure of RNA and complexes of RNA with oligonucleotides]. Dokl Akad Nauk (1996) 0.87
Mus cervicolor murine leukemia virus isolate M813 belongs to a unique receptor interference group. J Virol (2001) 0.87
[Transcriptional inhibition of human papilloma virus in cervical carcinoma cells reactivates functions of the tumor suppressor p53]. Mol Biol (Mosk) (2007) 0.86
Cell-specific effects of RAS oncogene and protein kinase C agonist TPA on P-glycoprotein function. FEBS Lett (1995) 0.86
Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53. Gene Ther (2004) 0.86
[Effect of on various cell lines of p53 cDNA, expressed under the control of an exogenous homologous promotor]. Mol Biol (Mosk) (1995) 0.86
[Modulation of activated oncogene c-kit expression with RNA-interference]. Mol Biol (Mosk) (2012) 0.85
[Functional heterogeneity of p53-responsive elements]. Mol Biol (Mosk) (1996) 0.85
Bidirectional promoters in the transcription of mammalian genomes. Biochemistry (Mosc) (2013) 0.85
Secondary structure of the 5'-region of PGY1/MDR1 mRNA. FEBS Lett (2000) 0.85
Cleavage of RNA with synthetic ribonuclease mimics. Methods Enzymol (2000) 0.85
A temperature-sensitive mutant of the myeloproliferative sarcoma virus, altered by a point mutation in the mos oncogene, has been modified as a selectable retroviral vector. J Virol (1987) 0.85
Hybridization of antisense oligonucleotides with the 3'part of tRNA(Phe). FEBS Lett (1999) 0.85
[Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells]. Mol Biol (Mosk) (2010) 0.85
[Down-regulation of TRIP6 expression induces actin cytoskeleton rearrangements in human carcinoma cell lines]. Mol Biol (Mosk) (2005) 0.84
Functional identification of secondary mutations inducing autonomous growth in synergy with a truncated interleukin-3 receptor: implications for multi-step oncogenesis. Exp Hematol (2001) 0.84
[Derivatives of oligonucleotides complementary to viral RNA inhibit replication of tick-borne encephalitis virus in a cell culture]. Dokl Akad Nauk SSSR (1988) 0.84
Cleavage of RNA by an amphiphilic compound lacking traditional catalytic groups. Bioorg Chem (2007) 0.84
Role of SHP2 for FLT3-dependent proliferation and transformation in 32D cells. Leukemia (2008) 0.84
Nucleic acids in exosomes: disease markers and intercellular communication molecules. Biochemistry (Mosc) (2013) 0.84
[Circulating nucleic acids in blood of patients with stomach and colon neoplasms]. Biomed Khim (2005) 0.84
Construction of a versatile set of retroviral vectors conferring hygromycin resistance. Biotechniques (1992) 0.84
[Sensitized photomodification by binary systems. I. Synthesis of oligonucleotide reagents, and the effect of their structure on the efficacy of target modification]. Bioorg Khim (1997) 0.84
Immunoproteasome enhances intracellular proteolysis of myelin basic protein. Dokl Biochem Biophys (2014) 0.84
[Transport of oligonucleotides-cell surface proteins complexes into cell nucleus]. Dokl Akad Nauk (1999) 0.84
Reduced proliferation of CD34(+) cells from patients with acute myeloid leukemia after gene transfer of INPP5D. Gene Ther (2009) 0.83